Department of Biology, Faculty of Science, Hacettepe University, Beytepe, Ankara, 06800, Turkey.
Endocrine. 2012 Dec;42(3):664-9. doi: 10.1007/s12020-012-9704-1. Epub 2012 May 29.
The aim of this study was to identify mutations in three different genes, the arginine-vasopressin-neurophysin II (AVP-NPII) gene, the arginine-vasopressin receptor 2 (AVPR2) gene, and the vasopressin-sensitive water channel aquaporin-2 (AQP2) gene in Turkish patients affected by central diabetes insipidus or nephrogenic diabetes insipidus. This study included 15 patients from unrelated families. Prospective clinical data were collected for all patients including the patients underwent a water deprivation-desmopressin test. The coding regions of the AVPR2, AQP2, and AVP-NPII genes were amplified by polymerase chain reaction and submitted to direct sequence analysis. Of the 15 patients with diabetes insipidus referred to Gulhane Military Medical Academy, Department of Endocrinology and Metabolism, eight patients have AVPR2 mutations, five patients have AQP2 mutations and two patients have AVP-NPII mutations. Of the patients, which have AVPR2 mutations, one is compound heterozygous for AVPR2 gene. Seven of these mutations are novel. Comparison of the clinical outcomes of these mutations may facilitate in understanding the functions of AVP-NPII, AQP2, and AVPR2 genes in future studies.
本研究旨在鉴定三种不同基因(精氨酸加压素-神经垂体素 II(AVP-NPII)基因、精氨酸加压素受体 2(AVPR2)基因和血管加压素敏感水通道 aquaporin-2(AQP2)基因)中的突变,这些基因在受中枢性尿崩症或肾性尿崩症影响的土耳其患者中。本研究纳入了 15 名无亲缘关系的患者。对所有患者(包括接受水剥夺-去氨加压素试验的患者)均采集了前瞻性临床数据。通过聚合酶链反应扩增 AVPR2、AQP2 和 AVP-NPII 基因的编码区,并进行直接序列分析。在被转诊到古尔哈内军事医学院内分泌和代谢科的 15 名尿崩症患者中,8 名患者存在 AVPR2 突变,5 名患者存在 AQP2 突变,2 名患者存在 AVP-NPII 突变。在这些有 AVPR2 突变的患者中,有一名为 AVPR2 基因的复合杂合突变。其中 7 种突变是新发现的。这些突变的临床结果的比较可能有助于未来研究中理解 AVP-NPII、AQP2 和 AVPR2 基因的功能。